vs
GCI Liberty, Inc.(GLIBA)与REPLIGEN CORP(RGEN)财务数据对比。点击上方公司名可切换其他公司
GCI Liberty, Inc.的季度营收约是REPLIGEN CORP的1.3倍($257.0M vs $197.9M),REPLIGEN CORP净利率更高(6.7% vs -150.6%,领先157.3%),GCI Liberty, Inc.自由现金流更多($21.0M vs $17.6M)
GCI通信公司(GCI Communication Corp)是一家运营于阿拉斯加的电信企业,依托自有基础设施及与其他供应商的合作,向当地客户提供互联网接入、固话及移动电话通讯服务,目前是GCI Liberty, Inc.的全资子公司。
Repligen是一家全球生命科学企业,专注于创新生物工艺技术与系统的研发及商业化,助力提升生物药生产效率。公司1981年成立,总部位于美国马萨诸塞州沃尔瑟姆,于纳斯达克挂牌上市,股票代码RGEN,截至2025年全球员工超1900人,主要服务生物制药领域客户。
GLIBA vs RGEN — 直观对比
营收规模更大
GLIBA
是对方的1.3倍
$197.9M
净利率更高
RGEN
高出157.3%
-150.6%
自由现金流更多
GLIBA
多$3.4M
$17.6M
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $257.0M | $197.9M |
| 净利润 | $-387.0M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | -189.9% | 9.0% |
| 净利率 | -150.6% | 6.7% |
| 营收同比 | — | 13.6% |
| 净利润同比 | — | 143.9% |
| 每股收益(稀释后) | $-13.34 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
GLIBA
RGEN
| Q4 25 | — | $197.9M | ||
| Q3 25 | $257.0M | $188.8M | ||
| Q2 25 | $261.0M | $182.4M | ||
| Q1 25 | — | $169.2M | ||
| Q4 24 | — | $174.1M | ||
| Q3 24 | — | $154.9M | ||
| Q2 24 | — | $154.1M | ||
| Q1 24 | — | $151.3M |
净利润
GLIBA
RGEN
| Q4 25 | — | $13.3M | ||
| Q3 25 | $-387.0M | $14.9M | ||
| Q2 25 | $27.0M | $14.9M | ||
| Q1 25 | — | $5.8M | ||
| Q4 24 | — | $-30.3M | ||
| Q3 24 | — | $-654.0K | ||
| Q2 24 | — | $3.3M | ||
| Q1 24 | — | $2.1M |
毛利率
GLIBA
RGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% | ||
| Q1 24 | — | 49.5% |
营业利润率
GLIBA
RGEN
| Q4 25 | — | 9.0% | ||
| Q3 25 | -189.9% | 8.9% | ||
| Q2 25 | 19.5% | 7.6% | ||
| Q1 25 | — | 3.9% | ||
| Q4 24 | — | -17.7% | ||
| Q3 24 | — | -5.1% | ||
| Q2 24 | — | 1.0% | ||
| Q1 24 | — | 1.3% |
净利率
GLIBA
RGEN
| Q4 25 | — | 6.7% | ||
| Q3 25 | -150.6% | 7.9% | ||
| Q2 25 | 10.3% | 8.2% | ||
| Q1 25 | — | 3.4% | ||
| Q4 24 | — | -17.4% | ||
| Q3 24 | — | -0.4% | ||
| Q2 24 | — | 2.2% | ||
| Q1 24 | — | 1.4% |
每股收益(稀释后)
GLIBA
RGEN
| Q4 25 | — | $0.24 | ||
| Q3 25 | $-13.34 | $0.26 | ||
| Q2 25 | — | $0.26 | ||
| Q1 25 | — | $0.10 | ||
| Q4 24 | — | $-0.55 | ||
| Q3 24 | — | $-0.01 | ||
| Q2 24 | — | $0.06 | ||
| Q1 24 | — | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $124.0M | $767.6M |
| 总债务越低越好 | $985.0M | $542.2M |
| 股东权益账面价值 | $1.4B | $2.1B |
| 总资产 | $3.0B | $2.9B |
| 负债/权益比越低杠杆越低 | 0.72× | 0.26× |
8季度趋势,按日历期对齐
现金及短期投资
GLIBA
RGEN
| Q4 25 | — | $767.6M | ||
| Q3 25 | $124.0M | $748.7M | ||
| Q2 25 | $104.0M | $708.9M | ||
| Q1 25 | — | $697.2M | ||
| Q4 24 | — | $757.4M | ||
| Q3 24 | — | $784.0M | ||
| Q2 24 | — | $809.1M | ||
| Q1 24 | — | $780.6M |
总债务
GLIBA
RGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | $985.0M | $537.9M | ||
| Q2 25 | $987.0M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益
GLIBA
RGEN
| Q4 25 | — | $2.1B | ||
| Q3 25 | $1.4B | $2.1B | ||
| Q2 25 | — | $2.1B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | — | $2.0B | ||
| Q3 24 | — | $2.0B | ||
| Q2 24 | — | $2.0B | ||
| Q1 24 | — | $2.0B |
总资产
GLIBA
RGEN
| Q4 25 | — | $2.9B | ||
| Q3 25 | $3.0B | $2.9B | ||
| Q2 25 | $3.4B | $2.9B | ||
| Q1 25 | — | $2.9B | ||
| Q4 24 | — | $2.8B | ||
| Q3 24 | — | $2.8B | ||
| Q2 24 | — | $2.9B | ||
| Q1 24 | — | $2.8B |
负债/权益比
GLIBA
RGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | 0.72× | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $76.0M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $21.0M | $17.6M |
| 自由现金流率自由现金流/营收 | 8.2% | 8.9% |
| 资本支出强度资本支出/营收 | 21.4% | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势,按日历期对齐
经营现金流
GLIBA
RGEN
| Q4 25 | — | $25.7M | ||
| Q3 25 | $76.0M | $48.1M | ||
| Q2 25 | $226.0M | $28.6M | ||
| Q1 25 | — | $15.0M | ||
| Q4 24 | — | $39.2M | ||
| Q3 24 | — | $49.3M | ||
| Q2 24 | — | $42.2M | ||
| Q1 24 | — | $44.7M |
自由现金流
GLIBA
RGEN
| Q4 25 | — | $17.6M | ||
| Q3 25 | $21.0M | $43.4M | ||
| Q2 25 | $107.0M | $21.5M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | — | $33.6M | ||
| Q3 24 | — | $42.3M | ||
| Q2 24 | — | $37.4M | ||
| Q1 24 | — | $36.4M |
自由现金流率
GLIBA
RGEN
| Q4 25 | — | 8.9% | ||
| Q3 25 | 8.2% | 23.0% | ||
| Q2 25 | 41.0% | 11.8% | ||
| Q1 25 | — | 6.8% | ||
| Q4 24 | — | 19.3% | ||
| Q3 24 | — | 27.3% | ||
| Q2 24 | — | 24.3% | ||
| Q1 24 | — | 24.0% |
资本支出强度
GLIBA
RGEN
| Q4 25 | — | 4.1% | ||
| Q3 25 | 21.4% | 2.5% | ||
| Q2 25 | 45.6% | 3.9% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | — | 4.5% | ||
| Q2 24 | — | 3.1% | ||
| Q1 24 | — | 5.5% |
现金转化率
GLIBA
RGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | — | 3.23× | ||
| Q2 25 | 8.37× | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 12.70× | ||
| Q1 24 | — | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图